Condition: Frailty · Sarcopenia · Sponsor: IRCCS San Raffaele
Observational study. Participants of the FRASNET study (9th March 2017, Protocol No. 24/INT/2017) who were evaluated in 2016 and 2017 will be contacted to be re-evaluated with multidimensional visits as part of the present study in order to assess trajectories and biomarkers of frailty and sarcopenia. Moreover, are going to evaluate with the same multidimensional visits patients with mild cognitive impairment and dementia followed up at the Neurologic Unit of the San Raffaele Hospital.
This description comes directly from the study's public registry record.
Patrizia Rovere Querini, PhD, MD · +390226433065 · rovere.patrizia@hsr.it
Sarah Damanti, PhD, MD · +390226433065 · damanti.sarah@hsr.it
Always discuss trial participation with your own doctor first.
| San Raffaele Hospital | Milan, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06324149